专利 等待形式审查

COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES

Overview

This Laos Patent “COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES” is a public DIP intellectual-property record, filed by KOH HWEE LING on 2017-03-08; current status: Awaiting formal examination. Identifiers include application No. P/595; DIP id LAP595; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/37、A61K 36/75、A61P 33/06. Inventor(s)/designer(s): KOH, Hwee Ling, LEE, Ying, TENG, Woon Chien Cecilia. Abstract hint: The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutic…. Status labels may change after office actions; refresh or consult primary DIP data before commercial decisions.

专利 老挝 DIP

申请号 P/595
申请日期 2017-03-08
申请人 KOH HWEE LING
代理机构 Lao Trademark Agency (LAO IP AGENCY)
类别 A61K 31/37 · A61K 36/75 · A61P 33/06

图样

下载

基础信息

类型
专利
申请号
P/595
状态
等待形式审查
申请人
KOH HWEE LING
代理机构
Lao Trademark Agency (LAO IP AGENCY)
申请日期
2017-03-08
公开/公告日
2026-02-27
国际分类
A61K 31/37 · A61K 36/75 · A61P 33/06
商品 / 服务

办理流程

根据当前状态动态标注
  1. 提交申请
  2. 形式审查 进行中
  3. 实质审查
  4. 公开
  5. 授权

关联分析

LaoBiz 企业数据库联动

摘要

The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.

The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.

提交咨询

留下联系方式,顾问将在工作时间内回复。

联系方式 * 点选后填写 · 至少一种
验证码 *
验证码

登录 LaoBiz

使用注册邮箱登录您的账号

或使用

使用 Google 登录

还没有账号?

或使用

使用 Google 注册

已有账号?

该社交账号未提供邮箱,请填写常用邮箱并完成验证后即可登录。